NCT04165278

Brief Summary

The aim of this study is to further evaluate the effects of seasonal variation and the aquatic thermal environment of hyperthermic baths (HTB) on the Motor Symptoms (MS) of Parkinson's Disease (PD), and whether the environmental temperature is associated with these effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable parkinson-disease

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2019

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 15, 2019

Completed
Last Updated

December 29, 2020

Status Verified

December 1, 2020

Enrollment Period

12 months

First QC Date

November 14, 2019

Last Update Submit

December 24, 2020

Conditions

Keywords

Parkinson's diseasetemperaturehyperthermic bathsphysiotherapy

Outcome Measures

Primary Outcomes (2)

  • The Influence of Hyperthermic Baths on Motor Symptoms as Assessed by the MDS-UPDRS Part III Motor Examination Total Scores Rating Scale

    The minimum and maximum values of Movement Disorder Society - United Parkinson's Disease Rating Scale (MDS-UPDRS) part III motor examination total scores are 0 and 132 respectively, and higher scores mean a worse outcome.

    3 week

  • The Influence of Hyperthermic Baths on Motor Symptoms as Assessed by the Modified Webster Symptoms Score

    The minimum and maximum values of Modified Webster Symptoms Score are 0 and 30 respectively, and higher scores mean a worse outcome.

    3 week

Study Arms (1)

Hyperthermic baths

EXPERIMENTAL

On the first, third and fifth day of the first week, each subject will take the Hyperthermic Baths (HTB) at the same time. They will receive subjective measures before and after HTB. In the second week, no subjects accepted any intervention. On the fifteenth, seventeenth and nineteenth days of the third week, these subjects will receive two subjective measures without HTB in the same environment and scoring time as the experimental group.

Other: hyperthermic baths

Interventions

Taking hyperthermic baths

Hyperthermic baths

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years of age
  • Diagnosis of Idiopathic Parkinson's Disease(IPD)based on the Movement Disorder Society clinical diagnostic criteria for Parkinson's Disease
  • Subjective feeling that Motor Symptoms(MS)of Parkinson's Disease (PD) were affected by seasonal variation (i.e., MS were more severe in winter than in summer) and improved after HTB
  • No change in the patient's PD medication regimen during the study

You may not qualify if:

  • Symptomatic bradycardia, severe postural hypotension, symptomatic coronary insufficiency, severe organic heart damage, severe cerebrovascular disease, and active psychosis
  • Dementia (Mini-Mental State Examination (MMSE) \< 24 and Montreal Cognitive Assessment (MOCA) \< 26)
  • Failure to cooperate with the study requirements and poor compliance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yingdong Zhang

Nanjing, Jiangsu, 210000, China

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Yingdong Zhang, PhD

    Nanjing Medical University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: a self-control study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2019

First Posted

November 15, 2019

Study Start

November 1, 2018

Primary Completion

October 18, 2019

Study Completion

October 18, 2019

Last Updated

December 29, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will share

we'll share our study design and the study results with other researchers

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
the data will become available 12 months after the study finished for 1 year
Access Criteria
clinical doctors

Locations